<DOC>
	<DOCNO>NCT02612038</DOCNO>
	<brief_summary>Obstructive sleep apnea ( OSA ) inherently site-specific . In physiological control intervention study , investigator seek determine whether apply expiratory resistance acutely improve ventilation sleep patient expiratory flow limitation ( EFL ) .</brief_summary>
	<brief_title>Nasal Expiratory Resistance Patients With Sleep Apnea Expiratory Flow Limitation</brief_title>
	<detailed_description>Collapse upper airway occur different site pharynx . One common recognizable form pharyngeal collapse prolapse soft palate ( velopharynx ) expiration , phenomenon refer expiratory flow limitation ( EFL ) . In principle , application nasal positive expiratory pressure reverse expiratory narrowing , increase ventilation , prevent subsequent progressive loss airflow lead arousal sleep , thereby improve OSA . One mean achieve expiratory pressure use add nasal expiratory resistance . Accordingly , single night protocol , investigator examine effect increase nasal expiratory resistance sleep . During obstructed breathing , patient switch acutely , random order , normal condition add expiratory resistance ( 30-80 cmH2O/L.s ) sham resistance , short ( 1 min ) prolong period ( 1 hour ) , repeatedly overnight . Patients participate study divide two group , exhibit EFL versus without EFL ( i.e . inspiratory flow limitation ) . The main outcome short physiologic intervention : - Increase ventilation , - Increased time respiratory-related arousal sleep , relative sham condition . The main outcome prolong intervention : -- Reduced frequency respiratory event ( AHI ; 3 % desaturation arousal ) relative sham condition . The central objective study test whether great improvement outcome EFL versus without EFL . This data allow u test whether expiratory resistance potential therapeutic benefit specifically patient EFL rather without EFL .</detailed_description>
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Sleep Apnea , Obstructive</mesh_term>
	<criteria>Presence obstructive sleep apnea ( AHI &gt; 10/hr ) Serious comorbidities include lung disease , heart disease , renal disease Medications affect respiration sleep Expiratory flow limitation ( EFL ) subgroup inclusion criterion : presence clear EFL polysomnographic study ( reduce flow increase pharyngeal pressure expiration predominant cause airflow obstruction ) . nonEFL subgroup inclusion criterion : complete absence EFL polysomnographic study</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Obstructive sleep apnea</keyword>
	<keyword>Expiratory flow limitation</keyword>
</DOC>